BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies
- 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt
- 2Faculty of Pharmacy, Al-Ahliyya Amman University Amman Jordan
Abstract
The rapid emergence of antimicrobial resistance (AMR) among Gram-negative pathogens has intensified the need for novel therapeutic strategies targeting previously underexploited bacterial systems. The β-barrel assembly machinery (BAM) complex, and particularly its central component BamA, has emerged as a highly promising antibacterial target due to its essential role in outer membrane protein (OMP) biogenesis and its accessibility at the bacterial surface. This review provides a comprehensive analysis of BamA structure, function, and mechanism, with emphasis on the dynamic lateral gate and β-augmentation processes that drive OMP folding and insertion. Recent advances in structural biology have enabled detailed characterization of BamA conformational states, offering critical insights into its druggability. We further present an integrated overview of the current BamA inhibitor landscape, including macrocyclic peptides, peptidomimetics, and small molecules, highlighting key structure–activity relationships (SAR) and binding modes. In addition, mechanisms of resistance, challenges associated with outer membrane (OM) permeability, and pharmacokinetic limitations are critically discussed. Particular attention is given to emerging design strategies that integrate conformational targeting, β-strand mimicry, and permeability optimization. Collectively, this review underscores the potential of BamA as a next-generation antibacterial target and outlines future directions for the development of effective therapeutics against multidrug-resistant Gram-negative bacteria.
Related
- Box–Behnken design optimization of Allium cepa (onion) peels extract-loaded chitosan nanoparticles for enhanced antibacterial and antioxidant activity with in-silico mechanistic insights
- Deciphering the mechanistic landscape of notch signaling in autoimmune pathogenesis
- Landscape restoration strategies differ in their predicted benefits for species persistence
- Advances and challenges in avian influenza vaccines: From conventional approaches to next-generation strategies
- CD8+ stem cell-like memory T cells: Unveiling the potential for next-generation vaccination strategies
BibTeX
@article{alkarmalawy2026bama,
title = {{BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies}},
author = {Ahmed A. Al-Karmalawy and Arwa Omar Al Khatib and Samia S. Hawas},
journal = {RSC advances},
year = {2026},
month = oct,
doi = {10.1039/d6ra06788c},
url = {https://europepmc.org/article/PMC/PMC13659652},
note = {CC BY},
}
RIS
TY - JOUR
TI - BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies
AU - Ahmed A. Al-Karmalawy
AU - Arwa Omar Al Khatib
AU - Samia S. Hawas
PY - 2026
DA - 2026/10/13
JO - RSC advances
DO - 10.1039/d6ra06788c
UR - https://europepmc.org/article/PMC/PMC13659652
AB - The rapid emergence of antimicrobial resistance (AMR) among Gram-negative pathogens has intensified the need for novel therapeutic strategies targeting previously underexploited bacterial systems. The β-barrel assembly machinery (BAM) complex, and particularly its central component BamA, has emerged as a highly promising antibacterial target due to its essential role in outer membrane protein (OMP) biogenesis and its accessibility at the bacterial surface. This review provides a comprehensive analysis of BamA structure, function, and mechanism, with emphasis on the dynamic lateral gate and β-augmentation processes that drive OMP folding and insertion. Recent advances in structural biology have enabled detailed characterization of BamA conformational states, offering critical insights into its druggability. We further present an integrated overview of the current BamA inhibitor landscape, including macrocyclic peptides, peptidomimetics, and small molecules, highlighting key structure–activity relationships (SAR) and binding modes. In addition, mechanisms of resistance, challenges associated with outer membrane (OM) permeability, and pharmacokinetic limitations are critically discussed. Particular attention is given to emerging design strategies that integrate conformational targeting, β-strand mimicry, and permeability optimization. Collectively, this review underscores the potential of BamA as a next-generation antibacterial target and outlines future directions for the development of effective therapeutics against multidrug-resistant Gram-negative bacteria.
SN - 2046-2069
ER -